In the univariable analysis, male (Odd Ratio [OR = 5.143], 95 % Confidence interval [95 % CI: 2.251‒11.751], p < 0.001), overweight (OR = 9.848, 95 % CI: 4.079‒23.776, p < 0.001), hypertriglyceridemia (OR = 6.015, 95 % CI: 1.629‒22.210, p = 0.007), hyperuricemia (OR = 7.825, 95 % CI: 2.154‒28.429, p = 0.002), metabolic-related risk (OR = 4.886, 95 % CI: 1.685‒14.165, p = 0.003), albumin (OR = 1.105, 95 % CI: 1.024‒1.191, p = 0.010), and FBG (OR = 1.754, 95 % CI: 1.042‒2.954, p = 0.034) were significantly associated with concomitant NAFLD. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.